Vulnerability to stressor-induced disturbances in self-stimulation from the dorsal and ventral A10 area: Differential effects of intraventricular D- Ala2-Met5-enkephalinamide, D-Ala2, N-Me-Phe4, Gly-Ol5-enkephalin, and D- Pen2 D-Pen5-enkephalin administration

Brain Research Bulletin

Volumn 47, Issue 3, 1998, Pages 237-248

  Zacharko, Robert M ^a   Maddeaux, Cindy ^a   Hebb, Andrea L O ^a   Mendella, Paul D ^b   Marsh, N Jill ^a  

^a CARLETON UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Anhedonia; D Ala2; D Ala2 Met5 enkephalinamide; D Pen2; DPen5 enkephalin; Footshock; Gly OIS enkephalin; Intracranial self stimulation; Intraventricular; Mouse; N Me Phe4; Ventral tegmental area

Indexed keywords

DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; METENKEPHALINAMIDE[2 DEXTRO ALANINE]; MU OPIATE RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DRUG EFFECT; ELECTRIC SHOCK; ELECTROSTIMULATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SELF STIMULATION; STRESS; VENTRAL TEGMENTUM;

ANIMALS; ELECTRIC STIMULATION; ELECTROSHOCK; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALIN, METHIONINE; ENKEPHALINS; FOOT; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED STRAINS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; SELF STIMULATION; STRESS; TEGMENTUM MESENCEPHALI; TIME FACTORS;

EID: 0032194213     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(98)00082-3     Document Type: Article

References (65)

1. Abercrombie E.D., Keefe K.A., DiFrischia D.F., Zigmond M.J. Differential effects of stress on in vivo dopamine release in the striatum, nucleus accumbens, and the medial frontal cortex. J. Neurochem. 52:1989;1655-1658.
2. Akiskal H.S., McKinney W.T. Depressive disorders Towards a unified hypothesis . Science. 182:1973;20-29.
3. Allen D., Johnson A.E., Tempel A., Zukin R.S., Luine V.N., McEwan B.S. Serotonergic lesions decrease μ and δ opiate receptor binding in discrete areas of hypothalamus and in the central grey. Brain Res. 625:1993;269-275.
4. Anisman H., Zacharko R.M. Depression The predisposing influence of stress . Behav. Brain Sci. 5:1982;89-173.
5. Anisman H., Zacharko R.M. Behavioral and neurochemical consequences associated with stressors. Ann. N.Y. Acad. Sci. 467:1986;205-225.
6. Arvidsson U., Dado R.J., Riedel M., Lee J.H., Law P.V., Loh H.H., Elde R., Wessendorf M.W. δ opioid receptor immunoreactivity Distribution in brain stem and spinal cord and relationship to biogenic amines and enkephalin . J. Neurosci. 15:1995;1215-1235.
7. Bannon M.J., Elliott P.J., Alpert J.E., Goedert M., Iversen S.D., Iversen L.L. Role of endogenous substance P in stress-induced activation of mesocortical dopamine neurones. Nature. 306:1983;791-792.
8. Bozarth M.A. Neuroanatomical boundaries of the reward-relevant opiate-receptor field in the ventral tegmental area as mapped by the conditioned place preference method in rats. Brain Res. 414:1987;77-84.
9. Brown G.W. Life events and affective disorder Implications and limitations . Psychosom. Med. 55:1993;248-259.
10. Cabib S., Puglisi-Allegra S. Opposite responses of mesolimbic dopamine system to controllable and uncontrollable aversive experiences. J. Neurosci. 14:1994;333-340.
11. Cabib S., Puglisi-Allegra S. Stress, depression and the mesolimbic dopamine system. Psychopharmacology. 128:1996;331-342.
12. Cameron D.L., Williams J.T. Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J. Neurosci. 14:1994;6763-6767.
13. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res. Rev. 18:1993;1-32.
14. Churchill L., Dilts R.P., Kalivas P.W. Autoradiographic localization of γ-aminobutyric acid A receptors within the ventral tegmental area. Neurochem. Res. 14:1992;101-106.
15. 3[H]DSTBULET, a new highly potent and selective linear enkephalin analogue. Neurochem. Intern. 16:1990;341-368.
16. Deutch A.Y., Bean A.J., Bisette G., Nemeroff C.B., Robbins R.J., Roth R.H. Stress-induced alterations in neurotensin, somatostatin and corticotropin-releasing factor in mesotelencephalic dopamine system regions. Brain Res. 414:1987;339-348.
17. Deutch A.Y., Tam S-Y, Roth R.H. Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra. Brain Res. 333:1985;143-146.
18. Devine D.P., Wise R.A. Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J. Neurosci. 14:1994;1978-1984.
19. Dilts R.P., Kalivas P.W. Autoradiographic localization of delta opioid receptors within the mesocorticolimbic dopamine system using radioligand DPDPE. Synapse. 6:1990;121-132.
20. Dziedzicka-Wasylewska M., Rogoz R. The effect of prolonged treatment with imipramine and electroconvulsive Shock on the levels of endogenous enkephalins in the nucleus accumbens and the ventral tegmentum of the rat. J. Neural Trans. 102:1995;221-228.
21. Genazzani A.R., Petraglia F., Fachinetti F., Scarone S., Brambilla F. Opioid plasma levels in primary affective disorders Effect of desipramine therapy . Neuropsychobiology. 12:1984;78-85.
22. German D.C., Speciale S.G., Manaye K., Sadeq M. Opioid receptors in midbrain dopaminergic regions of the rat. I. Mu receptor autoradiography. J. Neural Trans. 91:1993;39-52.
23. Halliday G.M., Tork I. Serotonin-like immunoreactive cells and fibres in the rat mesencephalic tegmentum. Brain Res. Bull. 22:1989;725-735.
24. Herve D., Pickel V.M., Joh T.H., Beuadet A. Serotonin axon terminals in the ventral tegmental area of the rat Fine structure and synaptic input to dopaminergic neurons . Brain Res. 435:1987;71-83.
25. Imperato A., Puglisi-Allegra S., Casolini P., Angelucci L. Changes in dopamine and acetylcholine release during and following stress are independent of the pituitary-adrenocortical axis. Brain Res. 538:1991;111-117.
26. Imperato A., Obinu M.C., Cabib S., Cestari S., Puglisi-Allegra S. Effects of subchronic minaprine on dopamine release in the ventral striatum and on immobility in the forced swimming test. Neurosci. Lett. 166:1994;69-72.
27. B synaptic potential in rat dopamine neurons. J. Neurosci. 208:1992;435-436.
28. Johnston P.I., Stellar J.R. Comparison of delta opiate receptor agonist induced reward and motor effects between the ventral pallidum and the dorsal striatum. Neuropharmacology. 33:1994;1171-1182.
29. Kalivas P.W. Interactions between neuropeptides and dopamine neurons in the ventromedial mesencephalon. Neurosci. Biobehav. Rev. 9:1985;573-587.
30. Kalivas P.W., Abhold R. Enkephalin release into the ventral tegmental area in response to stress Modulation of mesocorticolimbic dopamine . Brain Res. 414:1987;339-348.
31. Kalivas P.W., Duffy P., Eberhardt H. Modulation of A10 dopamine neurons by γ-aminobutyric acid agonists. J. Pharmacol. Exper. Ther. 253:1990;858-866.
32. Kalivas P.W., Churchill L., Klitenick M.A. GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience. 57:1993;1047-1060.
33. Kalyuzhny A.E., Wessendorf M.W. Relationship of μ- and δ-opioid receptors to gabaergic and dopaminergic neurons within the ventral tegmental area of rats. Soc. Neurosci. Abstr. 23:1997;679.
34. Kamata K., Yoshida S., Kameyama T. Antagonism of stress-induced inhibition of intracranial self-stimulation by naloxone or methamphetamine. Brain Res. 371:1986;197-200.
35. 3H-Spiperone to dopaminergic receptors. Gessa G.L., Serra G. Advances in the biosciences. 1990;555-558 Pergamon Press, Oxford.
36. Klitenick M.A., DeWitte P., Kalivas P.W. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA An in vivo microdialysis study . J. Neurosci. 12:1992;2623-2632.
37. Latimer L.G., Duffy P., Kalivas P.W. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. J. Pharmacol. Exp. Ther. 241:1987;328-337.
38. LeMoal M., Simon H. Mesocorticolimbic dopaminergic network Functional and regulatory roles . Physiol. Rev. 71:1991;155-234.
39. 5-enkephalinamide induces rapid recovery of responding for electrical brain stimulation from the ventral tegmental area following uncontrollable footshock. Brain Res. Bull. 28:1992;337-341.
40. Manzanares J., Durham R.A., Lookingland K.J., Moore K.E. δ-Opioid receptor-mediated regulation of central dopaminergic neurons. Eur. J. Pharmacol. 249:1993;107-112.
41. Miller J.D., Speciale S.G., McMillen B.A., German D.C. Naloxone antagonism of stress-induced augmentation of frontal cortex dopamine metabolism. Eur. J. Pharmacol. 98:1984;437-439.
42. Moreau J.L., Bourson A., Jenck F., Martin J.R., Mortas P. Curative effects of the atypical antidepressant mianserin in the chronic mild stress-induced anhedonia model of depression. J. Psychiatr. Neurosci. 19:1994;51-56.
43. Noel M.B., Wise R.A. Ventral tegmental injections of a selective μ or δ opioid enhance feeding in food-deprived rats. Brain Res. 673:1995;304-312.
44. Phillips A.G., LePiane F.G. Reinforcing effects of morphine microinjection into the ventral tegmental area. Pharmacol. Biochem. Behav. 12:1980;965-968.
45. Pollard H., Bouthenet M.L., Moreau J., Souil E., Verroust P., Ronco P., Schwartz J.C. Detailed immunoautoradiographic mapping of enkephalinase in rat central nervous system Comparison with enkephalins and substance P . Neuroscience. 30:1989;339-376.
46. Porecca F., Takemori A.E., Sultana M., Portoghese P.S., Bowen W.D., Mosberg H.I. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. J. Pharmacol. Exper. Ther. 263:1992;147-152.
47. Puglisi-Allegra S., Imperato A., Angelucci L., Cabib S. Acute stress induces time-dependent responses in dopamine mesolimbic system. Brain Res. 554:1991;217-222.
48. Rosetti Z.L., Lai M., Hmaidan Y., Gessa G.L. Depletion of mesolimbic dopamine during behavioral despair Partial reversal by chronic imipramine . Eur. J. Pharmacol. 242:1993;313-315.
49. Shanks N., Zalcman S., Zacharko R.M., Anisman H. Alterations of central norepinephrine, dopamine and serotonin in several strains of mice following acute stressor exposure. Pharm. Biochem. Behav. 38:1991;69-75.
50. Sidman R.L., Angevine J.B., Taber-Pierce E. Atlas of the mouse brain and spinal cord. 1971;Harvard University Press, Cambridge.
51. Sorg B.A., Kalivas P.W. Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex. Neuroscience. 89:1992;2046-2050.
52. Speciale S.G., Manaye K.F., Sadeq M., German D.C. Opioid receptors in midbrain dopaminergic regions of the rat. II. Kappa and delta receptor autoradiography. J. Neural Trans. 91:1993;53-66.
53. Suzuki T., Yoshiike M., Mizoguchi H., Kamei J., Misawa M., Nagase H. Blockade of δ-opioid receptors prevents morphine-induced place preference in mice. Jpn. J. Pharmacol. 66:1994;131-137.
54. Tanaka M., Ida Y., Tsuda A., Tsujimaru S., Shirao I., Oguchi M. Met-enkephalin, injected during the early phase of stress, attenuates stress-induced increases in noradrenaline release in rat brain regions. Pharm. Biochem. Behav. 32:1989;791-795.
55. Weiss J.M., Simson P.E. Electrophysiology of the locus coeruleus Implications for stress-induced depression . Koob G.F., Ehlers C.L., Kupfer D.J. Animal models of depression. 1989;111-134 Birkhauser, Boston.
56. B and NMDA receptor agonists on medial forebrain bundle self-stimulation. Behav. Brain Res. 70:1995;31-36.
57. Wolfe C., Zacharko R.M. Desmethylimipramine promotes recovery of self-stimulation from the prefrontal cortex following footshock. Brain Res. Bull. 27:1991;601-604.
58. Yoburn B.C., Lutfy K., Candido J. Species differences in μ- and δ-opioid receptors. Eur. J. Pharmacol. 193:1991;105-108.
59. Zacharko R.M. Stressors, the mesocorticolimbic system, and anhedonia Implications for PTSD . Murburg M.M. Catecholamine function in posttraumatic stress disorder. 1994;99-130 American Psychiatric Press, Washington.
60. Zacharko R.M., Anisman H. Stressor-provoked alterations of intracranial self-stimulation in the mesocorticolimbic system An animal model of depression . Willner P., Scheel-Kruger J. The mesolimbic dopamine system From motivation to action . 1990;411-442 John Wiley, London.
61. Zacharko R.M., Anisman H. Pharmacological, biochemical and behavioral analyses of depression Animal models . Koob G.F., Ehlers C.L., Kupfer D.J. Animal models of depression. 1989;204-238 Birhauser, Boston.
62. Zacharko R.M., Anisman H. Stressor-induced anhedonia in the mesocorticolimbic system. Neurosci. Biobehav. Rev. 15:1991;391-405.
63. Zacharko R.M., Bowers W.J., Kelley M.S., Anisman H. Prevention of stressor induced disturbances of self-stimulation by desmethylimipramine. Brain Res. 321:1984;175-179.
64. Zacharko R.M., Bowers W.J., Kokkinidis L., Anisman H. Region-specific reductions of intracranial self-stimulation after uncontrollable stress Possible effects on reward processes . Behav. Brain Res. 9:1983;129-141.
65. Zacharko R.M., Kasian M., MacNeil G., Anisman H. Stressor-induced behavioral alterations in intracranial self-stimulation from the ventral tegmental area Evidence for regional variations . Brain Res. Bull. 25:1990;617-621.